Does this mean while the current shareholding is diluted by circa 35%, the discount given is circa 20% assuming the current share price $1.50?
- Forums
- ASX - By Stock
- SGR
- Ann: Appendix 4D & 2023 Half-Year Financial Report
Ann: Appendix 4D & 2023 Half-Year Financial Report, page-16
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGR (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.0¢ |
Change
-0.010(1.96%) |
Mkt cap ! $1.441B |
Open | High | Low | Value | Volume |
50.5¢ | 51.0¢ | 49.5¢ | $4.476M | 8.939M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 913651 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 1049946 | 58 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 925898 | 0.500 |
30 | 1396660 | 0.495 |
32 | 775483 | 0.490 |
22 | 685566 | 0.485 |
46 | 2064833 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 1049946 | 58 |
0.510 | 1538167 | 30 |
0.515 | 1123847 | 23 |
0.520 | 2130329 | 34 |
0.525 | 1554513 | 13 |
Last trade - 15.36pm 15/07/2024 (20 minute delay) ? |
Featured News
SGR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online